CLEVELAND – University Hospitals (UH) Seidman Cancer Center hematologist-oncologist Leland Metheny, MD, is leading the trial. He says in the two years since the foundational pre-clinical work was ...
University Hospitals (UH) Seidman Cancer Center hematologist-oncologist Leland Metheny, MD, is leading the trial. He says in the two years since the foundational pre-clinical work was completed, the ...
January 2022 debuted Reshmi Parameswaran's novel B-cell activating factor (BAFF) CAR T product effective at killing multiple B-cell cancers with robust in vitro and in vivo cytotoxicity exerted by ...
Luminary Therapeutics (Luminary Tx) and Case Western Reserve University have entered into a formal collaboration agreement that includes an option for Luminary to exclusively license a novel BAFF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback